Skip to main content
Top
Published in: Surgery Today 7/2012

01-07-2012 | Original Article

The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer

Authors: Junichi Nishiyama, Mitsumasa Matsuda, Satoko Ando, Miyoko Hirasawa, Toshiyasu Suzuki, Hiroyasu Makuuchi

Published in: Surgery Today | Issue 7/2012

Login to get access

Abstract

Purpose

The goal of this retrospective study was to evaluate the effects of perioperative administration of sivelestat sodium hydrate, a selective neutrophil elastase inhibitor, on the clinical course after radical surgery for esophageal cancer.

Methods

The effects of sivelestat on postoperative systemic inflammatory reactions and respiratory function were examined in 53 patients who underwent radical surgery for esophageal cancer between April 2004 and March 2005 with (n = 26, sivelestat group) and without (n = 27, control group) the administration of sivelestat.

Results

The average age in the sivelestat group was higher than that in the control group, but there were no other differences in the background factors between the two groups. The postoperative oxygenation (PaO2/FiO2 ratio) did not differ between the groups, but the decrease in oxygen saturation (SpO2) was significantly inhibited in the sivelestat group compared with the control group (p < 0.01). A significant inhibition of the increase in the CRP level also occurred in the sivelestat group (p < 0.01). The patients in the sivelestat group were also hospitalized for shorter periods compared to those in the control group.

Conclusion

The early administration of sivelestat to patients receiving radical surgery for esophageal cancer can inhibit postoperative systemic inflammatory reactions and it might also have a beneficial effect on the prognosis.
Literature
1.
go back to reference Nakae H, Endo S, Inada K, Kasai T, Yoshida M. Significance of α-tocopherol and interleukin 8 in septic adult respiratory distress syndrome. Res Commun Chem Pathol Pharmacol. 1994;84:197–202.PubMed Nakae H, Endo S, Inada K, Kasai T, Yoshida M. Significance of α-tocopherol and interleukin 8 in septic adult respiratory distress syndrome. Res Commun Chem Pathol Pharmacol. 1994;84:197–202.PubMed
2.
go back to reference Endo S, Inada K, Inoue Y, Kuwata Y, Suzuki M, Yamashita H, et al. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock. 1992;38:264–74.PubMed Endo S, Inada K, Inoue Y, Kuwata Y, Suzuki M, Yamashita H, et al. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock. 1992;38:264–74.PubMed
3.
go back to reference Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H, et al. Plasma tumor necrosis factor-α (TNF-α) levels in patients with burns. Burns. 1993;19:124–7.PubMedCrossRef Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H, et al. Plasma tumor necrosis factor-α (TNF-α) levels in patients with burns. Burns. 1993;19:124–7.PubMedCrossRef
4.
go back to reference Endo S, Inada K, Yamashita H, Takakuwa T, Nakae H, Kasai T, et al. Platelet activating factor (PAF) acetylhydrolase activity type II phosholipase A2, and cytokine levels in patients with sepsis. Res Commun Chem Pathol Pharmacol. 1994;83:289–95.PubMed Endo S, Inada K, Yamashita H, Takakuwa T, Nakae H, Kasai T, et al. Platelet activating factor (PAF) acetylhydrolase activity type II phosholipase A2, and cytokine levels in patients with sepsis. Res Commun Chem Pathol Pharmacol. 1994;83:289–95.PubMed
5.
go back to reference Endo S, Inada K, Ceska M, Takakuwa T, Yamada Y, Nakae H, et al. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J Inflammation. 1995;45:136–42. Endo S, Inada K, Ceska M, Takakuwa T, Yamada Y, Nakae H, et al. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J Inflammation. 1995;45:136–42.
6.
go back to reference Tanaka T, Sugimoto H, Yoshikawa T, Sugimoto T. Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure. Ann Surg. 1991;213:81–5.PubMedCrossRef Tanaka T, Sugimoto H, Yoshikawa T, Sugimoto T. Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure. Ann Surg. 1991;213:81–5.PubMedCrossRef
7.
go back to reference Petty TL. Protease mechanisms in the pathogenesis of acute lung injury. Ann NY Acad Sci. 1991;624:267–77.PubMedCrossRef Petty TL. Protease mechanisms in the pathogenesis of acute lung injury. Ann NY Acad Sci. 1991;624:267–77.PubMedCrossRef
8.
go back to reference Yachida S, Wakabayashi H, Kokudo Y, Goda F, Okada S, Maeba T, et al. Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg. 2000;24:359–64.PubMedCrossRef Yachida S, Wakabayashi H, Kokudo Y, Goda F, Okada S, Maeba T, et al. Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg. 2000;24:359–64.PubMedCrossRef
9.
go back to reference Committee for Preparation of ARDS Guidelines of the Japanese Respiratory Society. Guidelines for Treatment of ALI/ARDS, Tokyo: Shujunsha; 2005. Committee for Preparation of ARDS Guidelines of the Japanese Respiratory Society. Guidelines for Treatment of ALI/ARDS, Tokyo: Shujunsha; 2005.
10.
go back to reference Hyoba R, Satomi S. Changes in cytokines after surgery for esophageal cancer. Rinshogeka (Jpn J Clin Surg). 1997;52:583–9. (in Japanese). Hyoba R, Satomi S. Changes in cytokines after surgery for esophageal cancer. Rinshogeka (Jpn J Clin Surg). 1997;52:583–9. (in Japanese).
11.
go back to reference Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, et al. Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine. 1994;6:181–6.PubMedCrossRef Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, et al. Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine. 1994;6:181–6.PubMedCrossRef
12.
go back to reference Sato N, Hida K, Ikeda K, Oysuka K, Kimura Y, Aoki K, et al. Effect of preoperative methylprednisolone on esophageal surgical stress. Nihon Syokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg). 1997;30889:1831–8. (in Japanese).CrossRef Sato N, Hida K, Ikeda K, Oysuka K, Kimura Y, Aoki K, et al. Effect of preoperative methylprednisolone on esophageal surgical stress. Nihon Syokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg). 1997;30889:1831–8. (in Japanese).CrossRef
13.
go back to reference Yoshida K, Nishihira T, Hyoba R, Nakano T, Akaishi T, Hirayama K, et al. Administration experience of urinastatin in cases ofoperation of thoracic esophagus cancer cases. Renal function and granulocytic elastase. Rinshotokenkyu (Jpn J Clin Exp Med) 1990;67: 2601–04 (in Japanese). Yoshida K, Nishihira T, Hyoba R, Nakano T, Akaishi T, Hirayama K, et al. Administration experience of urinastatin in cases ofoperation of thoracic esophagus cancer cases. Renal function and granulocytic elastase. Rinshotokenkyu (Jpn J Clin Exp Med) 1990;67: 2601–04 (in Japanese).
14.
go back to reference Ono S, Aosasa S, Mochizuki H. Effects of protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg. 1999;177:78–82.PubMedCrossRef Ono S, Aosasa S, Mochizuki H. Effects of protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg. 1999;177:78–82.PubMedCrossRef
15.
go back to reference Arakawa H, Iwakoshi H, Sakamoto K. Changes in interleukin-8 (IL-8) and neutrophil elastase in bronchoalveolar lavage (BAL) after surgery for esophageal cancer. Biotherapy. 1993;7:736–8. (in Japanese). Arakawa H, Iwakoshi H, Sakamoto K. Changes in interleukin-8 (IL-8) and neutrophil elastase in bronchoalveolar lavage (BAL) after surgery for esophageal cancer. Biotherapy. 1993;7:736–8. (in Japanese).
16.
go back to reference Reid PT, Donnnelly SC, MacGregor IR, Grant IS, Cameron E, Walker W, et al. Pulmonary endothelial permeability and circulating neutrophil–endothelial markers in patients undergoing esophagogastrectomy. Crit Care Med. 2000;28:3161–5.PubMedCrossRef Reid PT, Donnnelly SC, MacGregor IR, Grant IS, Cameron E, Walker W, et al. Pulmonary endothelial permeability and circulating neutrophil–endothelial markers in patients undergoing esophagogastrectomy. Crit Care Med. 2000;28:3161–5.PubMedCrossRef
17.
go back to reference Weiss SJ, Curnutte JT, Regiani S. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J Immunol. 1986;136:636–41.PubMed Weiss SJ, Curnutte JT, Regiani S. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J Immunol. 1986;136:636–41.PubMed
18.
go back to reference Doi K, Yamanaka K, Tsuneyoshi H. Effectiveness of Sivelestat sodium at the postoperative management against acute lung injury after type a acute aortic dissection. Prog Med. 2006;26:2264–6. (in Japanese). Doi K, Yamanaka K, Tsuneyoshi H. Effectiveness of Sivelestat sodium at the postoperative management against acute lung injury after type a acute aortic dissection. Prog Med. 2006;26:2264–6. (in Japanese).
19.
go back to reference Nishibe T, Kondo Y, Muto A, Dardik A, Ohara Y, Kainuma M, et al. Protective effect of sivelestat sodium (Elaspol®) on postoperative lung dysfunction in patients with type A acute aortic dissection: a pilot study. J Cardiovasc Surg (Torino). 2008;49:627–31. Nishibe T, Kondo Y, Muto A, Dardik A, Ohara Y, Kainuma M, et al. Protective effect of sivelestat sodium (Elaspol®) on postoperative lung dysfunction in patients with type A acute aortic dissection: a pilot study. J Cardiovasc Surg (Torino). 2008;49:627–31.
20.
go back to reference Furusawa T, Tsukioka K, Fukui D, Sakaguchi M, Seto T, Terasaki T, et al. The effects of a neutrophil elastase inhibitor on the postoperative respiratory failure of acute aortic dissection. Thorac Cardiovasc Surg. 2006;54:404–7.PubMedCrossRef Furusawa T, Tsukioka K, Fukui D, Sakaguchi M, Seto T, Terasaki T, et al. The effects of a neutrophil elastase inhibitor on the postoperative respiratory failure of acute aortic dissection. Thorac Cardiovasc Surg. 2006;54:404–7.PubMedCrossRef
21.
go back to reference Ryugo M, Sawa Y, Takano H, Matsumiya G, Iwai S, Ono M, et al. Effect of a polymorphonuclear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: findings of a double-blind randomized study. Surg Today. 2006;36:321–6.PubMedCrossRef Ryugo M, Sawa Y, Takano H, Matsumiya G, Iwai S, Ono M, et al. Effect of a polymorphonuclear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: findings of a double-blind randomized study. Surg Today. 2006;36:321–6.PubMedCrossRef
22.
go back to reference Minami T, Kashira K. Usefulness of perioperative sivelestat sodium in thoracic aorta replacement. Masui (Jpn J Anesthesi). 2006;55:977–82. (in Japanese). Minami T, Kashira K. Usefulness of perioperative sivelestat sodium in thoracic aorta replacement. Masui (Jpn J Anesthesi). 2006;55:977–82. (in Japanese).
23.
go back to reference Drug interview form ‘Elaspol 100 for injection’, revised in August 2005. 5th edn. p. 24. Drug interview form ‘Elaspol 100 for injection’, revised in August 2005. 5th edn. p. 24.
24.
go back to reference Kadota Y, Nakura H, Ichikawa K, Mitaka C. Respiratory management patients after surgery for esophageal cancer in ICU. Rinshomasui (Jpn J Clin Anesth). 1997;21:1049–54. (in Japanese). Kadota Y, Nakura H, Ichikawa K, Mitaka C. Respiratory management patients after surgery for esophageal cancer in ICU. Rinshomasui (Jpn J Clin Anesth). 1997;21:1049–54. (in Japanese).
25.
go back to reference Takemura M, Osugi H, Ri E, Kaneko M, Tanaka Y, Fujiwara Y, et al. Trial of invasion reduction in esophageal cancer complete cure excision by elastase inhibitor. Rinshoto kenkyu (Jpn J Clin Exp Med). 2003;80:2289–92. (in Japanese). Takemura M, Osugi H, Ri E, Kaneko M, Tanaka Y, Fujiwara Y, et al. Trial of invasion reduction in esophageal cancer complete cure excision by elastase inhibitor. Rinshoto kenkyu (Jpn J Clin Exp Med). 2003;80:2289–92. (in Japanese).
26.
go back to reference Ono S, Tsujimoto H, Hiraki S, Takahata R, Kimura A, Kinoshita M, Ichikura T, Mochizuki H. Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy. World J Surg. 2007;31:1996–2001.PubMedCrossRef Ono S, Tsujimoto H, Hiraki S, Takahata R, Kimura A, Kinoshita M, Ichikura T, Mochizuki H. Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy. World J Surg. 2007;31:1996–2001.PubMedCrossRef
27.
go back to reference Sasajima K, Futami R, Matsutani T, Nomura T, Makino H, Maruyama H, Miyashita M. Increases in soluble tumor necrosis factor receptors coincide with increases in interleukin-6 and proteinases after major surgery. Hepatogastroenterology. 2009;56:1377–81.PubMed Sasajima K, Futami R, Matsutani T, Nomura T, Makino H, Maruyama H, Miyashita M. Increases in soluble tumor necrosis factor receptors coincide with increases in interleukin-6 and proteinases after major surgery. Hepatogastroenterology. 2009;56:1377–81.PubMed
28.
go back to reference Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, Saikawa Y, Ueda M, Yamada S, Tasaka S, Funakoshi Y, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitajima M. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus. 2007;20:478–86.PubMedCrossRef Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, Saikawa Y, Ueda M, Yamada S, Tasaka S, Funakoshi Y, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitajima M. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus. 2007;20:478–86.PubMedCrossRef
29.
go back to reference Akamoto S, Okano K, Sano T, Yachida S, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y. Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery. Surg Today. 2007;37:359–65.PubMedCrossRef Akamoto S, Okano K, Sano T, Yachida S, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y. Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery. Surg Today. 2007;37:359–65.PubMedCrossRef
30.
go back to reference Kawahara Y, Ninomiya I, Fujimura T, Funaki H, Nakagawara H, Takamura H, Oyama K, Tajima H, Fushida S, Inaba H, Kayahara M. Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus. 2010;23:329–39.PubMedCrossRef Kawahara Y, Ninomiya I, Fujimura T, Funaki H, Nakagawara H, Takamura H, Oyama K, Tajima H, Fushida S, Inaba H, Kayahara M. Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus. 2010;23:329–39.PubMedCrossRef
31.
go back to reference Hoshi K, Yamamoto Y, Shibusawa M, Saito K, Agatsuma T, Kameyama Y, et al. The fluctuation of the circulatory blood volume during abdominal aortic aneurysm repair. Prog Med. 2008;28:1259–64. (in Japanese). Hoshi K, Yamamoto Y, Shibusawa M, Saito K, Agatsuma T, Kameyama Y, et al. The fluctuation of the circulatory blood volume during abdominal aortic aneurysm repair. Prog Med. 2008;28:1259–64. (in Japanese).
Metadata
Title
The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer
Authors
Junichi Nishiyama
Mitsumasa Matsuda
Satoko Ando
Miyoko Hirasawa
Toshiyasu Suzuki
Hiroyasu Makuuchi
Publication date
01-07-2012
Publisher
Springer Japan
Published in
Surgery Today / Issue 7/2012
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-011-0105-5

Other articles of this Issue 7/2012

Surgery Today 7/2012 Go to the issue